Spontaneous Bacterial Peritonitis: An Unusual Life-Threatening Complication of Congestive Heart Failure

2015 ◽  
Vol 31 (5) ◽  
pp. 691.e13-691.e14 ◽  
Author(s):  
John P. Rossiter ◽  
Kristopher Cunningham ◽  
Paul N. Manley
Keyword(s):  
Heart Failure ◽  
Congestive Heart Failure ◽  
Spontaneous Bacterial Peritonitis ◽  
Bacterial Peritonitis ◽  
Life Threatening ◽  
Life Threatening Complication

scholarly journals BrucellaEndocarditis as a Late Onset Complication of Brucellosis

2015 ◽  
Vol 2015 ◽  
pp. 1-3
Author(s):  
Panagiotis Andriopoulos ◽  
Christos Antoniou ◽  
Panagiota Manolakou ◽  
Athanassios Vasilopoulos ◽  
George Assimakopoulos ◽  
...  
Keyword(s):  
Heart Failure ◽  
Congestive Heart Failure ◽  
Case Report ◽  
Aortic Valve ◽  
Valve Replacement ◽  
Antibiotic Treatment ◽  
Late Onset ◽  
Life Threatening ◽  
Life Threatening Complication

Brucellaendocarditis (BE) is a rare but life threatening complication ofbrucellosis. We present a case report of a patient with relapsing brucellosis complicated with aortic valve endocarditis. The patient underwent valve replacement and required prolonged antibiotic treatment because of rupture of the noncoronary leaflet and development of congestive heart failure. Since the onset of endocarditis in patients with brucellosis is not known, proper follow-up is required in order to identify any late onset complications, especially in endemic areas.

scholarly journals A COMPREHENSIVE INFORMATIVE NOTE ON ASCITES

2018 ◽  
Vol 11 (4) ◽  
pp. 154
Author(s):  
Navneet Singh ◽  
Sazal Patyar ◽  
Naveen Chandra Talniya
Keyword(s):  
Quality Of Life ◽  
Heart Failure ◽  
Congestive Heart Failure ◽  
Spontaneous Bacterial Peritonitis ◽  
Early Stage ◽  
Abdominal Distension ◽  
Medical Practitioners ◽  
Bacterial Peritonitis ◽  
Loss Of Appetite

 Ascites impairs both the physical and mental dimensions of quality of life in patients. The patients due to unawareness do not report to medical practitioners in the early stage of disease, and also in few cases, medical practitioners due to lack of adequate expertise face difficulty to ensure the early stage detection for causes of ascites, i.e., due to cirrhosis, cancer, congestive heart failure, mycobacterium tuberculosis, or others. Ascites is a symptom of progression of single disease or multiple diseases. Gross collection of fluid in peritoneal cavity may initiate a series of problems such as spontaneous bacterial peritonitis and an increase in abdominal distension and discomfort and hinder the mobility of the patient and dullness and loss of appetite. In the present review, a detail study over the ecology of ascites has been done with emphasizing on diagnosis by history and physical examination, clinical examination, and imagining techniques followed by management of treatment through general guidelines, and various available therapies are covered.

scholarly journals Necrotizing myopathy presenting as congestive heart failure and life-threatening ventricular arrhythmias: a case report

2021 ◽  
Vol 5 (6) ◽  
Author(s):  
Kyunghee Lim ◽  
Jong Sung Park ◽  
Byeol-A Yoon ◽  
Song-Hee Han
Keyword(s):  
Heart Failure ◽  
Congestive Heart Failure ◽  
Ventricular Arrhythmias ◽  
High Dose ◽  
Respiratory Impairment ◽  
Motor Weakness ◽  
High Dose Steroid ◽  
Necrotizing Autoimmune Myopathy ◽  
Life Threatening ◽  
Autoimmune Myopathy

Abstract Background Necrotizing autoimmune myopathy is a rare subtype of idiopathic inflammatory myopathy; however, it can be associated with fatal cardiac manifestations. Case summary A 58-year-old female patient was referred for congestive heart failure with dysrhythmia. Electrocardiograms showed ventricular arrhythmias of various QRS complex morphologies and coupling intervals with beat-to-beat differences. Despite optimal medical therapy for heart failure, the patient was admitted for the progression of dyspnoea and generalized motor weakness. The burden of non-sustained ventricular tachycardia gradually increased, and ventricular fibrillation eventually occurred. In view of a differential diagnosis of an inflammatory myocardial diseases such as sarcoidosis, a cardiac biopsy was performed. However, pathologic examinations revealed only necrotic muscle fibres without granuloma. Further examinations revealed proximal dominant motor weakness, an elevated serum creatinine-phosphokinase level, myogenic potentials on needle electromyography, and biceps muscle biopsy findings that were compatible with necrotizing autoimmune myopathy. High-dose steroid therapy improved the patient’s motor weakness, including her respiratory impairment, and successfully suppressed ventricular arrhythmias. Discussion This case suggests that intensive immunosuppressive therapy with high-dose steroid could be useful in the necrotizing autoimmune myopathy manifested as congestive heart failure and life-threatening ventricular arrhythmias.

The Association between T-Wave Morphology and Life-Threatening Ventricular Tachyarrhythmias in Patients with Congestive Heart Failure

2009 ◽  
Vol 32 (9) ◽  
pp. 1173-1177 ◽  
Author(s):  
YEN-HUNG LIN ◽  
LIAN-YU LIN ◽  
YING-SHREN CHEN ◽  
HUI-CHUN HUANG ◽  
JEN-KUANG LEE ◽  
...  
Keyword(s):  
Heart Failure ◽  
Congestive Heart Failure ◽  
Ventricular Tachyarrhythmias ◽  
T Wave ◽  
Wave Morphology ◽  
Life Threatening

P0200KEEP ON (KEEPING RAAS INHIBITION TREATMENT WITH OPTIMAL POTASSIUM CONTROL). DESIGN OF A CLINICAL TRIAL OF USING SODIUM ZIRCONIUM CYCLOSILICATE FOR KEEPING RAAS INHIBITION AND/OR MRAS IN PATIENTS WITH CKD AND CONGESTIVE HEART FAILURE HISTORY

2020 ◽  
Vol 35 (Supplement_3) ◽  
Author(s):  
Maria Jesãºs Puchades Montesa ◽  
Nayara Panizo Gonzalez ◽  
Luis D'Marco ◽  
Miguel Gonzalez-Rico ◽  
Patricia Tomas ◽  
...  
Keyword(s):  
Heart Failure ◽  
Congestive Heart Failure ◽  
Cardiorenal Syndrome ◽  
Serum Electrolytes ◽  
Sodium Zirconium ◽  
Multifrequency Bioimpedance ◽  
Threatening Condition ◽  
Life Threatening ◽  
Sodium Zirconium Cyclosilicate ◽  
Nephroprotective Effect

Abstract Background and Aims Hyperkalemia (HK) is a potentially life-threatening condition, in patients with chronic kidney disease (CKD) and congestive heart failure (CHF). The majority of patients affected with CKD or CHF, must be treated with inhibitors of renin angiotensin aldosterone system (RAASi) and mineralocorticoid receptor antagonists (MRAs). However, the treatments previously mentioned, increase the risk of HK episodes, which is the main cause of RAASi and MRAs downtitration or discontinuation, representing an undesirable clinical scenario, given that the patients are at high risk of be deprived of their nephroprotective effect and cardio-renal benefits The aim of the study is: to analyze if, in patients with HK, CKD and CHF treated with RAASi and/or MRA, serum potassium (sK) reduction by Sodium zirconium cyclosilicate (SZC) treatment is non-inferior to RAASi and/or MRAs discontinuation or downtitration. Method Results The study will demonstrate results on serum electrolytes, renal function, albuminuria, KDQoL questionnaire and changes in relative overhydration (multifrequency bioimpedance -BCM Fresenius-) Conclusion The KEEP ON study will define the ability of SZC to facilitate the use of RAAS-I and / or MRA in patients with HK and cardiorenal syndrome allowing the maintenance of the medications recommended by international guidelines for the treatment of CHF at different degrees of CKD while maintaining the potential cardio-renal and nephroprotective benefit.

Effect of Proton Pump Inhibitors on Mortality in Patients with Cirrhosis and Spontaneous Bacterial Peritonitis

2018 ◽  
Vol 17 (5) ◽  
pp. 0-10
Author(s):  
Tsung-Hsing Hung ◽  
Chih-Wei Tseng ◽  
Hsing-Feng Lee ◽  
Chih-Chun Tsai ◽  
Chen-Chi Tsai
Keyword(s):  
Gastrointestinal Bleeding ◽  
Proton Pump Inhibitors ◽  
Proton Pump ◽  
Spontaneous Bacterial Peritonitis ◽  
Cox Regression ◽  
Bacterial Peritonitis ◽  
Hazard Ratios ◽  
Short Term Mortality ◽  
Life Threatening ◽  
Taiwan National Health Insurance

Introduction and aim. Spontaneous bacterial peritonitis (SBP) is a life-threatening infection in patients with cirrhosis. However, it is unknown whether patients with SBP and cirrhosis who do not have active gastrointestinal bleeding have a poorer prognosis if treated with proton pump inhibitors (PPI). Material and methods. We used the Taiwan National Health Insurance Database to identify 858 patients with SBP and cirrhosis who were administered PPIs and hospitalized between January 1, 2010, and December 31, 2013. One-to-two propensity score matching was performed to select a comparison group based on age, gender, and comorbidities. All patients obtained follow-up for 1 year. Results: The overall 30-day, 90-day, and 1-year mortality was 27.9%, 49.0%, and 73.7%, respectively, in the PPI group and 25.6%, 43.8%, and 67.2%, respectively, in the non-PPI group. After adjusting the Cox regression model for age, gender, and comorbidities, the hazard ratios for PPIs regarding 30-day, 30- to 90-day, and 90-day to 1-year mortality were 1.074 (95% CI 0.917-1.257, P = 0.377), 1.390 (95% CI 1.154-1.673, P = 0.001), and 1.297 (95% CI 1.099-1.531, P = 0.002), respectively. Conclusions: PPIs did not increase the short-term mortality of patients with SBP and cirrosis who did not have active gastrointestinal bleeding, but PPIs increased the long-term mortality risk. For these patients, physicians should discontinue PPIs as early as possible.

Ascites, Spontaneous Bacterial Peritonitis, and Hepatorenal Syndrome

2015 ◽  
Author(s):  
Fredric D. Gordon
Keyword(s):  
Web Sites ◽  
Spontaneous Bacterial Peritonitis ◽  
Hepatorenal Syndrome ◽  
Treatment Options ◽  
Screening Tests ◽  
Refractory Ascites ◽  
Bacterial Peritonitis ◽  
Life Threatening ◽  
Associated Conditions ◽  
Primary Focus

Ascites, a common occurrence in cirrhotic patients with portal hypertension, is the pathologic accumulation of fluid in the peritoneum. Associated conditions are spontaneous bacterial peritonitis (SBP) and hepatorenal syndrome (HRS). SBP occurs in 30% of patients with ascites and carries a 20% mortality, most often due to the severity of the underlying cirrhosis. HRS involves life-threatening sequela of refractory ascites with limited treatment options; a review that focuses exclusively on this disease can be found elsewhere in this section. The development of these diseases is a poor prognostic feature, and referral for liver transplantation should be a consideration. This review examines ascites, SBP, and HRS and their relation to each other. The primary focus is ascites, addressing its epidemiology, pathophysiology, diagnosis, differential diagnosis, and management. Figures show theories of ascites formation and pathophysiology of HPS. Tables list screening tests on ascitic fluid, serum ascites–albumin gradient, drugs and agents to avoid in patients with ascites, diagnostic criteria for HPS, and clinical features of type 1 HPS. Also included are two recommended, pertinent Web sites for those who wish to learn more about ascites, SBP, and HPS. This review contains 2 highly rendered figures, 5 tables, and 73 references.

Managing Hemangiomas

PEDIATRICS ◽  
1991 ◽  
Vol 87 (4) ◽  
pp. 582-583
Author(s):  
CAROLE HURVITZ ◽  
ARIE ALKALAY
Keyword(s):  
Heart Failure ◽  
Congestive Heart Failure ◽  
Life Threatening ◽  
Intrahepatic Tumor

To the Editor.— We read with interest the article, "Management of Alarming Hemangiomas in Infancy: A Review of 25 Cases" by Enjolras et al, in the April, 1990 issue of Pediatrics. We note that all three patients with liver hemangiomas died. We would like to draw your attention to two articles that we have published with regard to treatment of life-threatening hemangiomas with cyclophosphamide.1,2 In our series of four patients, the very large intrahepatic tumor resistant to prednisone in one infant who also had congestive heart failure completely resolved with two courses of cyclophosphamide.

Life-threatening congestive heart failure as the presentation of centronuclear myopathy

1987 ◽  
Vol 3 (2) ◽  
pp. 117-120 ◽  
Author(s):  
Sidney M. Gospe ◽  
Dawna L. Armstrong ◽  
Mary V. Gresik ◽  
Hal K. Hawkins
Keyword(s):  
Heart Failure ◽  
Congestive Heart Failure ◽  
Centronuclear Myopathy ◽  
Life Threatening

Immunosuppressive Drugs in Heart Transplantation

2019 ◽  
pp. 83-147
Author(s):  
Sule Apikoglu-Rabus ◽  
Murat B. Rabus ◽  
Rashida Muhammad Umar
Keyword(s):  
Heart Failure ◽  
Congestive Heart Failure ◽  
Heart Disease ◽  
Adverse Effects ◽  
Heart Transplantation ◽  
Chronic Rejection ◽  
Cardiac Transplantation ◽  
Immunosuppressive Drugs ◽  
Life Threatening ◽  
End Stage

Congestive heart failure affects 23 million people worldwide [1]. Cardiac transplantation provides a lifesaving treatment for patients with end-stage heart disease. It offers a longer life with a higher quality to those who have no other treatment alternative. Although cardiac transplantation offers a relief from heart immunosuppression. The goal of immunosuppression immediately following surgery is to prevent hyperacute and acute rejections. Transplantation immunosuppression must be balanced in order to prevent rejection while minimizing the serious adverse effects of therapy including life-threatening infections and malignancies. Immunosuppressive regimens are classified as induction, maintenance, or anti-rejection regimens. Induction regimens consist of intense early post-operative immunosuppression while maintenance regimens are used indefinitely for prevention of acute and chronic rejection. This chapter will review the induction and maintenance immunosuppressive regimens used in heart transplantation with summaries of selected literature as well as the most common complications of these therapies and significant drug-drug interactions.

Sign in / Sign up

Export Citation Format

Share Document